These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 23812328)

  • 21. [Anything that can go wrong: cytotoxic cells and their control of Epstein-Barr virus].
    Gutiérrez-Guerrero A; Espinosa-Padilla SE; Lugo-Reyes SO
    Rev Alerg Mex; 2024 Feb; 71(1):29-39. PubMed ID: 38683066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
    Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
    Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.
    Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P
    Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection.
    Chijioke O; Müller A; Feederle R; Barros MH; Krieg C; Emmel V; Marcenaro E; Leung CS; Antsiferova O; Landtwing V; Bossart W; Moretta A; Hassan R; Boyman O; Niedobitek G; Delecluse HJ; Capaul R; Münz C
    Cell Rep; 2013 Dec; 5(6):1489-98. PubMed ID: 24360958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease.
    Hatton OL; Harris-Arnold A; Schaffert S; Krams SM; Martinez OM
    Immunol Res; 2014 May; 58(2-3):268-76. PubMed ID: 24619311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases.
    Latour S; Fischer A
    Immunol Rev; 2019 Sep; 291(1):174-189. PubMed ID: 31402499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma.
    Strowig T; Brilot F; Arrey F; Bougras G; Thomas D; Muller WA; Münz C
    PLoS Pathog; 2008 Feb; 4(2):e27. PubMed ID: 18266470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus immunossuppression of innate immunity mediated by phagocytes.
    Savard M; Gosselin J
    Virus Res; 2006 Aug; 119(2):134-45. PubMed ID: 16545476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [An analysis of immunophenotyping of peripheral lymphocytes in adult patients with infectious mononucleosis and chronic active Epstein-Barr virus infection].
    Xie J; Wang HL; Qiu ZF; Li TS
    Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):455-9. PubMed ID: 27256608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune Evasion by Epstein-Barr Virus.
    Ressing ME; van Gent M; Gram AM; Hooykaas MJ; Piersma SJ; Wiertz EJ
    Curr Top Microbiol Immunol; 2015; 391():355-81. PubMed ID: 26428381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4+ T cell responses in the immune control against latent infection by Epstein-Barr virus.
    Paludan C; Münz C
    Curr Mol Med; 2003 Jun; 3(4):341-7. PubMed ID: 12776989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cells.
    MacArthur GJ; Wilson AD; Birchall MA; Morgan AJ
    J Virol; 2007 May; 81(9):4766-75. PubMed ID: 17314172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell-mediated immunity during Epstein-Barr virus infections in children.
    Liu M; Wang R; Xie Z
    Infect Genet Evol; 2023 Aug; 112():105443. PubMed ID: 37201619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of human natural killer cells during Epstein-Barr virus infection.
    Münz C
    Crit Rev Immunol; 2014; 34(6):501-7. PubMed ID: 25597312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma.
    Zhu QY; Kong XW; Sun C; Xie SH; Hildesheim A; Cao SM; Zeng MS
    mSphere; 2020 Dec; 5(6):. PubMed ID: 33268566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder.
    Martinez OM; Krams SM
    Transplantation; 2017 Sep; 101(9):2009-2016. PubMed ID: 28376031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
    Serafini B; Rosicarelli B; Veroni C; Mazzola GA; Aloisi F
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
    Otto C; Hofmann J; Ruprecht K
    Med Hypotheses; 2016 Jun; 91():109-113. PubMed ID: 27142157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disorders.
    Martorelli D; Muraro E; Merlo A; Turrini R; Faè DA; Rosato A; Dolcetti R
    Clin Dev Immunol; 2012; 2012():931952. PubMed ID: 22319542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection.
    Tsuge I; Morishima T; Kimura H; Kuzushima K; Matsuoka H
    J Med Virol; 2001 Jun; 64(2):141-8. PubMed ID: 11360246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.